⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABUS News
Arbutus Biopharma Corporation Common Stock
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
globenewswire.com
ABUS
ROIV
MRNA
Form 8-K
sec.gov
ABUS
Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
ABUS
Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025
globenewswire.com
ABUS